- Abstract
- INTRODUCTION
- MATERIALS AND METHODS
- RESULTS
- DISCUSSION
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A108038789
Mudan Cai (한국한의학연구원) ; Jun-Hwan Lee ; Eun Jin Yang
2021
English
528
KCI등재
학술저널
121-133(13쪽)
0
0
상세조회0
다운로드목차 (Table of Contents)
참고문헌 (Reference)
1 Liu WY, "Tight junction in blood-brain barrier : an overview of structure, regulation, and regulator substances" 18 : 609-615, 2012
2 Lin XM, "The impact of different duration of EA-pretreatment on expression of MMP-9 and VEGF in blood-brain barrier in rats with cerebral ischemia-reperfusion injury" 40 : 40-44, 2015
3 Magaki S, "The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier" 70 : 70-77, 2018
4 Zenaro E, "The blood-brain barrier in Alzheimer’s disease" 107 : 41-56, 2017
5 Kalaria RN, "The blood-brain barrier and cerebrovascular pathology in Alzheimer’s disease" 893 : 113-125, 1999
6 Michalicova A, "Tau protein and its role in blood-brain barrier dysfunction" 13 : 570045-, 2020
7 Cai M, "TDP-43 modification in the hSOD1G93A amyotrophic lateral sclerosis mouse model" 37 : 253-262, 2015
8 Cai Z, "Role of blood-brain barrier in Alzheimer’s disease" 63 : 1223-1234, 2018
9 Dong H, "Repeated electroacupuncture preconditioning attenuates matrix metalloproteinase-9 expression and activity after focal cerebral ischemia in rats" 31 : 853-858, 2009
10 Yu X, "Neurovascular unit dysfunction and neurodegenerative disorders" 14 : 334-, 2020
1 Liu WY, "Tight junction in blood-brain barrier : an overview of structure, regulation, and regulator substances" 18 : 609-615, 2012
2 Lin XM, "The impact of different duration of EA-pretreatment on expression of MMP-9 and VEGF in blood-brain barrier in rats with cerebral ischemia-reperfusion injury" 40 : 40-44, 2015
3 Magaki S, "The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier" 70 : 70-77, 2018
4 Zenaro E, "The blood-brain barrier in Alzheimer’s disease" 107 : 41-56, 2017
5 Kalaria RN, "The blood-brain barrier and cerebrovascular pathology in Alzheimer’s disease" 893 : 113-125, 1999
6 Michalicova A, "Tau protein and its role in blood-brain barrier dysfunction" 13 : 570045-, 2020
7 Cai M, "TDP-43 modification in the hSOD1G93A amyotrophic lateral sclerosis mouse model" 37 : 253-262, 2015
8 Cai Z, "Role of blood-brain barrier in Alzheimer’s disease" 63 : 1223-1234, 2018
9 Dong H, "Repeated electroacupuncture preconditioning attenuates matrix metalloproteinase-9 expression and activity after focal cerebral ischemia in rats" 31 : 853-858, 2009
10 Yu X, "Neurovascular unit dysfunction and neurodegenerative disorders" 14 : 334-, 2020
11 Bell RD, "Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer’s disease" 118 : 103-113, 2009
12 Yang EJ, "Neuroprotective effects of electroacupuncture on an animal model of bilateral common carotid artery occlusion" 53 : 7228-7236, 2016
13 Tejera D, "Microglia in neurodegenerative disorders" 2034 : 57-67, 2019
14 Song YY, "Mechanisms of electroacupuncture on Alzheimer’s disease : a review of animal studies" 26 : 473-480, 2020
15 Dubenko OE, "Levels of proinflammatory cytokines Il-17 and Il-23in patients with Alzheimer’s disease, mild cognitive impairment and vascular dementia" 74 : 68-71, 2021
16 Gorlé N, "Interferons : a molecular switch between damage and repair in ageing and Alzheimer’s disease" 183 : 111148-, 2019
17 Yamamoto M, "Interferon-γ and tumor necrosis factor-α regulate amyloid-β plaque deposition and β-secretase expression in Swedish mutant APP transgenic mice" 170 : 680-692, 2007
18 Choi SS, "Human astrocytes : secretome profiles of cytokines and chemokines" 9 : e92325-, 2014
19 Winkler EA, "GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration" 18 : 521-530, 2015
20 Tackenberg C, "Familial Alzheimer’s disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system" 15 : e0239584-, 2020
21 Feng Y, "FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients" 30 : 672-682, 2012
22 Lu KW, "Electroacupuncture restores spatial learning and downregulates phosphorylated N-methyl-D-aspartate receptors in a mouse model of Parkinson’s disease" 35 : 133-141, 2017
23 Xu A, "Electroacupuncture protects cognition by regulating tau phosphorylation and glucose metabolism via the AKT/GSK3β signaling pathway in Alzheimer’s disease model mice" 14 : 585476-, 2020
24 Jung YS, "Electroacupuncture preconditioning reduces ROS generation with NOX4 down-regulation and ameliorates blood-brain barrier disruption after ischemic stroke" 23 : 32-, 2016
25 Cai M, "Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model" 16 : 264-, 2019
26 Li K, "Electroacupuncture ameliorates neuroinflammation-mediated cognitive deficits through inhibition of NLRP3 in presenilin1/2 conditional double knockout mice" 2021 : 8814616-, 2021
27 Zhang J, "Electroacupuncture : a new approach to open the blood-brain barrier in rats recovering from middle cerebral artery occlusion" 36 : 377-385, 2018
28 Xu H, "Effects of acupuncture at GV20 and ST36 on the expression of matrix metalloproteinase 2, aquaporin 4, and aquaporin 9 in rats subjected to cerebral ischemia/reperfusion injury" 9 : e97488-, 2014
29 Yang ZX, "Effect of electroacupuncture combined with Donepezil on learning-memory ability and expression of hippocampal β-amyloid clearance-related genes in SAMP8 mice" 45 : 281-286, 2020
30 Steeland S, "Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease" 10 : e8300-, 2018
31 Breijyeh Z, "Comprehensive review on Alzheimer’s disease : causes and treatment" 25 : 5789-, 2020
32 Zlokovic BV, "Clearance of amyloid β-peptide from brain : transport or metabolism" 6 : 718-, 2000
33 Italiani P, "Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease : new markers of disease progression" 15 : 342-, 2018
34 Li J, "Changes in cerebral glucose metabolism after acupuncture at KI3 in spontaneously hypertensive rats : a positron emission tomography study" 37 : 107-115, 2019
35 Desai BS, "Blood-brain barrier pathology in Alzheimer’s and Parkinson’s disease : implications for drug therapy" 16 : 285-299, 2007
36 Sweeney MD, "Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders" 14 : 133-150, 2018
37 Alvarez XA, "Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate Alzheimer disease" 29 : 237-252, 1996
38 Gezen-Ak D, "BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer’s disease or mild cognitive impairment" 37 : 185-195, 2013
39 Kook SY, "Aβ1–42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling" 32 : 8845-8854, 2012
40 Wan W, "Aβ1–42 oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins" 134 : 382-393, 2015
41 Yao Y, "Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity" 5 : 3413-, 2014
42 Kang Z, "Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis" 32 : 414-425, 2010
43 Kamat PK, "Astrocyte mediated MMP-9 activation in the synapse dysfunction : an implication in Alzheimer disease" 1 : e243-, 2014
44 Park JC, "Annexin A1 restores Aβ1–42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway" 16 : 149-161, 2017
45 Marco S, "Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells" 401 : 219-224, 2006
46 Carrano A, "Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy" 15 : 1167-1178, 2011
47 Querfurth HW, "Alzheimer’s disease" 362 : 329-344, 2010
48 Burns A, "Alzheimer’s disease" 338 : b158-, 2009
49 Chen S, "Acupuncture at the Taixi(KI3)acupoint activates cerebral neurons in elderly patients with mild cognitive impairment" 9 : 1163-1168, 2014
50 Zhu B, "Acupuncture at KI3 in healthy volunteers induces specific cortical functional activity : an fMRI study" 15 : 361-, 2015
51 Huang HC, "Accumulated amyloid-β peptide and hyperphosphorylated tau protein : relationship and links in Alzheimer’s disease" 16 : 15-27, 2009
Protective effects of folic acid on colon carcinogenesis induced by azoxymethane in mice
Sudden cardiac death as a naturally-occurring ventricular hypertrophy in Macaca fascicularis
Congestive heart failure caused by myxomatous mitral valve degeneration in a Siberian tiger
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2022 | 평가예정 | 계속평가 신청대상 (계속평가) | |
2021-12-01 | 평가 | 등재후보로 하락 (재인증) | |
2018-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2016-01-04 | 학술지명변경 | 한글명 : Journal of Biomedical Research -> Journal of Biomedical and Translational Research외국어명 : Journal of Biomedical Research -> Journal of Biomedical and Translational Research | |
2015-01-01 | 평가 | 등재학술지 선정 (계속평가) | |
2013-01-01 | 평가 | 등재후보학술지 유지 (기타) | |
2011-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.03 | 0.03 | 0.07 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.08 | 0.07 | 0.306 | 0.04 |